International Clinical Trial: Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469306) titled 'Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer' on March 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fujian Cancer Hospital

Condition: Locally Advanced Rectal Cancer

Intervention: Radiation: Modified Short-course radiotherapy Radiation: Long-course radiotherapy Drug: Oxaliplatin Drug: Capecitabine Drug: Tislelizumab Drug: Capecitabine

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enro...